Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies a...(tinued) 59 Miscellaneous Antiemetics ...),Health

Miscellaneous Antiemetics (Continued) 59

TABLE 8 MARKETED ANTIEMETIC PRODUCTS 60

TABLE 8 (CONTINUED) 61

MARKET SIZE AND GROWTH 61

TABLE 9 GLOBAL PRESCRIPTION ANTIEMETIC MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 61

FIGURE 5 GLOBAL PRESCRIPTION ANTIEMETIC MARKET BY REGION, 2007-2014 ($ MILLIONS) 62

COMPETITIVE STRUCTURE AND MARKET SHARE 62

TABLE 10 GLOBAL PRESCRIPTION ANTIEMETIC REVENUES AND MARKET SHARE BY MANUFACTURER, 2009 ($ MILLIONS/%) 63

FIGURE 6 GLOBAL PRESCRIPTION ANTIEMETICS REVENUES BY MANUFACTURER, 2009 ($ MILLIONS) 63

GASTROINTESTINAL CANCER TREATMENTS 63

GASTROINTESTINAL CANCER (CONTINUED) 64

GASTROINTESTINAL CANCER (CONTINUED) 65

TABLE 11 MARKETED GASTROINTESTINAL CANCER PRODUCTS 66

MARKET SIZE AND GROWTH 66

TABLE 12 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER DRUG MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 66

FIGURE 7 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER DRUG MARKET BY REGION, 2007-2014 ($ MILLIONS) 67

COMPETITIVE STRUCTURE AND MARKET SHARE 67

TABLE 13 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER DRUG REVENUES AND MARKET SHARE, 2009 ($ MILLIONS/%) 68

FIGURE 8 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER DRUG REVENUES, 2009 ($ MILLIONS) 68

H2 INHIBITORS 68

H2 INHIBITORS (CONTINUED) 69

H2 INHIBITORS (CONTINUED) 70

H2 INHIBITORS (CONTINUED) 71

TABLE 14 MARKETED H2 INHIBITORS PRODUCTS 72

MARKET SIZE AND GROWTH 72

TABLE 15 GLOBAL PRESCRIPTION H2 INHIBITOR MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 73

FIGURE 9 GLOBAL PRESCRIPTION H2 INHIBITOR MARKET BY REGION, 2007-2014 ($ MILLIONS) 73

COMPETITIVE STRUCTURE AND MARKET SHARE 73

TABLE 16 GLOBAL PRESCRIPTION H2 INHIBITOR REVENUES AND MARKET SHARE, 2009 ($ MILLIONS/%) 74